Form 4: Standex International Director Sells Shares
Insider Transaction Filing
Standex International Director Thomas E. Chorman reported a sale of 50 shares of common stock on April 1, 2026, executed under a pre-existing 10b5-1 trading plan.
Summary
- Thomas E. Chorman, a Director at Standex International Corporation, sold 50 shares of common stock on April 1, 2026.
- The transaction was conducted under a Rule 10b5-1 trading plan established on November 6, 2025.
- Following this transaction, Mr. Chorman beneficially owns 12,566 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it represents a routine transaction under a pre-established trading plan by a director, rather than a significant strategic event or performance indicator.
Negatives
- Director Thomas E. Chorman sold 50 shares of common stock.
Future Outlook
No specific future outlook or guidance is provided in this filing.
Industry Context
StockSavvy.ai notes that Form 4 filings, like this one from Standex International, are standard disclosures for insider transactions. The use of a 10b5-1 plan indicates a pre-arranged trading strategy designed to avoid concerns about insider trading, which is a common practice among corporate executives and directors.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| 10b5-1 Trading Plan | Director Thomas E. Chorman executed a sale of common stock under a pre-existing Rule 10b5-1 trading plan. | 2026-04-01 | Demonstrates adherence to established trading policies designed to prevent insider trading concerns. |
Stakeholder Impact
- Shareholders: The sale of shares by a director, even under a 10b5-1 plan, may be observed by investors, though the pre-arranged nature mitigates concerns about adverse non-public information.
Key Dates
| Date | Description |
|---|---|
| 2025-11-06 | Date of the Rule 10b5-1 trading plan establishment. |
| 2026-04-01 | Transaction date for the sale of common stock. |
| 2026-04-03 | Date of the signature on the filing. |
Keywords
Standex International, SXI, Form 4, Insider Trading, 10b5-1 Plan, Stock Sale, Director Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.